Starling Oncology Institute share price logo

Starling Oncology Institute

NASDAQ: TOI

$5.13

+0.27

(+5.56%)

as on

Bell Icon

This instrument is not available for trading on the INDmoney app on 3 Aug 2026

Starling Oncology Institute Stock Performance

as on August 4, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $4.87
    $5.15
    downward going graph

    5.07%

    Downside

    0.39%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $2.32
    $6.67
    downward going graph

    54.78%

    Downside

    30.02%

    Upside

    downward going graph

Starling Oncology Institute share price movements today

Previous Close
$4.86
Open
$4.94
Volume
1.2M
Day's Low - High
$4.87 - $5.15
52 Week Low - High
$2.32 - $6.67

Starling Oncology Institute Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Starling Oncology Institute Stock Fundamentals & Key Indicators

Check Starling Oncology Institute market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$-

EPS (TTM)

-0.3

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-21

Industry PE ratio

0.00

PEG Ratio

0.31

EBITDA

-21.9M

Revenue (TTM)

587.2M

Profit Margin

15.69%

Return On Equity TTM

209.81%

Starling Oncology Institute vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Starling Oncology Institute with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Starling Oncology Institute image
Starling Oncology Institute
Buy$-NA-21.0015.69%0.00%
Tenet Healthcare image
Tenet Healthcare
StrongBuy$21.2B287.50%7.6829.38%0.00%
DaVita image
DaVita
Buy$11.5B76.17%13.9830.96%0.00%
Encompass Health image
Encompass Health
StrongBuy$13.5B116.87%20.8038.53%0.58%
HCA Healthcare image
HCA Healthcare
Buy$97.7B105.70%15.2921.69%0.66%
See all

Analyst Recommendation on Starling Oncology Institute Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Starling Oncology Institute. Average target price of $8.4

Starling Oncology Institute Share Price Target

Get share price movements and forecasts by analysts on Starling Oncology Institute.

What analysts predicted

38.93%UPSIDE

Target Price

$8.4

Current Price

$5.13

Analyzed by

1 Analysts

High

$11

Target

$8.40

Low

$11

Starling Oncology Institute target price $8.4, a slight upside of 38.93% compared to current price of $5.13. According to 1 analysts rating.

Starling Oncology Institute Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
94
98
99
100
104
119
136
141
147
161
Gross Profit
11
13
14
14
17
17
18
22
23
27
Operating Income
-17
-16
-13
-11
-9
-11
-8
-6
-6
-4
EBITDA
-16
-11
-12
-10
-12
-13
-12
-3
1
-6
Interest Expense
1
2
2
1
5
1
1
1
1
1
Depreciation
1
1
1
1
1
1
1
1
1
1
Income Before Tax
-19
-15
-16
-13
-19
-17
-16
-7
-2
-9
Income Tax Expense
-
-
-
-
-
0
-
-
-
-
Net Income
-19
-15
-16
-13
-19
-17
-16
-7
-2
-9
Net Profit Margin
12.64%
13.21%
14.38%
14.60%
16.52%
14.61%
13.85%
16.04%
15.81%
16.84%

Starling Oncology Institute Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
155
187
203
252
324
393
502
Gross Profit
29
36
40
52
59
53
76
Operating Income
-2
-8
-45
-81
-77
-60
-36
EBITDA
0
-11
-42
-67
-54
-50
-42
Interest Expense
0
0
0
4
6
7
11
Depreciation
2
3
3
4
5
6
6
Income Before Tax
-2
-14
-11
0
-83
-64
-60
Income Tax Expense
1
0
0
0
0
-
0
Net Income
-4
-14
-10
0
-83
-64
-60
Net Profit Margin
19.27%
19.67%
20.12%
20.63%
18.37%
13.73%
15.20%

Starling Oncology Institute Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-16
-12
-16
-13
-19
-17
-16
-7
-2
-9
Operating Cash Flow
-15
-15
0
4
-4
-10
-12
3
-2
11
Investing Cash Flow
19
18
10
-1
0
-1
0
-1
-1
0
Financing Cash Flow
0
-2
0
0
-4
1
10
3
0
0
Change in Cash
2
0
10
2
-9
-9
-2
5
-3
10

Starling Oncology Institute Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-4
-14
-10
0
-83
-53
-60
Operating Cash Flow
3
0
-32
-61
-36
-26
-24
Investing Cash Flow
-1
-8
-12
-131
62
46
-3
Financing Cash Flow
0
11
154
92
-6
-3
11
Change in Cash
2
3
109
-101
19
16
-16

Global Institutional Holdings in Starling Oncology Institute

Check out the Institutions with significant holdings in Starling Oncology Institute.

Funds
Holdings
Vanguard
4.25%
VANGUARD INDEX FUNDS
3.39%
James E. Flynn
3.36%
iShares
3.03%
Charles Davidson
1.71%
See all

Starling Oncology Institute News & Key Events

  • img

    Today's Timeline - 07 July

    Tue, 06:30 PM

    -

    Oncology Institute repays $86 million convertible note with new $75 million term loan from OrbiMed, enhancing liquidity and extending debt maturities.

Insights on Starling Oncology Institute

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, TOI has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, TOI stock has moved up by 98.1%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 21 quarters, 48.57M → 147.44M (in $), with an average increase of 5.3% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 5 quarters, -19.58M → -2.49M (in $), with an average increase of 84.8% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, DaVita Inc. has given 67.5% return, outperforming this stock by 40.2%

About Starling Oncology Institute

Starling Oncology, Inc., formerly The Oncology Institute, is a value-based oncology company advancing cancer care in the community setting. Founded in 2007, the company offers cutting-edge, evidence-based cancer treatments, including clinical trials and transfusions, to a large patient population. It operates as an integrated oncology platform serving patients, providers, and health plans across multiple markets with a focus on delivering high-quality, patient-centered care.
OrganisationStarling Oncology Institute
Headquarters18000 Studebaker Road, Suite 800, Cerritos, CA, 90703, US
IndustryMedical - Care Facilities
CEODaniel Virnich

FAQs

What is Starling Oncology Institute share price today?

Starling Oncology Institute share price today is $5.13 as on at the close of the market. Starling Oncology Institute share today touched a day high of $5.15 and a low of $4.87.

What is the 52 week high and 52 week low for Starling Oncology Institute share?

Starling Oncology Institute share touched a 52 week high of $6.67 on and a 52 week low of $2.32 on . Starling Oncology Institute stock price today i.e. is closed at $5.13,which is 23.09% down from its 52 week high and 121.12% up from its 52 week low.

How to invest in Starling Oncology Institute Stock (TOI) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Starling Oncology Institute on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Starling Oncology Institute Stock (TOI) from India?

Indian investors can start investing in Starling Oncology Institute (TOI) shares with as little as ₹94.4749984741211 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹944.75 in Starling Oncology Institute stock (as per the Rupee-Dollar exchange rate as on ). Based on Starling Oncology Institute share’s latest price of $5.13 as on August 4, 2026 at 8:46 am IST, you will get 1.9493 shares of Starling Oncology Institute. Learn more about fractional shares .